76.80PLN+6.52%Mkt Cap: 713.21M PLNP/E: —Last update: 2026-06-01
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of comp…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap713.21M PLN
Enterprise Value660.33M PLN
Revenue (TTM)—
Gross Profit-166.00K PLN
Net Income (TTM)-6.72M PLN
Revenue/Share—
Last Price76.80 PLN
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLMDNCE00016
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-98.82
EV/Revenue—
P/S—
P/B7.45
EPS (TTM)-0.86
EPS (Forward)—
52W Range
6.74094% of range81.50
52W High81.50 PLN
52W Low6.740 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-7.63%
ROA-7.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.58M PLN
CapEx (TTM)6.07M PLN
FCF Margin—
FCF Yield-1.25%
Net Debt-9.24M PLN
Net Debt/EBITDA1.38
Balance Sheet
Debt/Equity0.00
Current Ratio6.87
Quick Ratio6.85
Book Value/Sh9.673 PLN
Cash/Share1.034 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.29M
Float5.77M
Insiders22.49%
Institutions15.48%
Technical
SMA 5063.77 (+20.4%)
SMA 20030.63 (+150.7%)
Beta1.16
S&P 52W Chg27.94%
Avg Vol (30d)54.59K
Avg Vol (10d)38.06K
Technical Indicators
RSI (14)53.4
MACD2.7045
MACD Signal3.3012
MACD Hist.-0.5968
BB Upper77.15 PLN
BB Middle72.05 PLN
BB Lower66.95 PLN
BB Width14.15%
ATR (14)4.094 PLN
Vol Ratio (20d)0.69x